Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Liver Diseases

  Free Subscription


Articles published in Am J Gastroenterol

Retrieve available abstracts of 295 articles:
HTML format



Single Articles


    July 2021
  1. MOCTEZUMA-VELAZQUEZ C, Abraldes JG
    Statins and Liver Cancer in Cirrhosis: The Most Relevant Questions Are Still Unanswered.
    Am J Gastroenterol. 2021 Jul 19. pii: 00000434-990000000-00051.
    PubMed     Abstract available


  2. LABENZ C, Labenz J
    Proton Pump Inhibitors in Patients With Liver Cirrhosis: Evidence to Improve Their Battered Reputation.
    Am J Gastroenterol. 2021 Jul 19. pii: 00000434-990000000-00048.
    PubMed    


  3. USHIDA K, Shimizu M, Yamamoto Y, Momosaki R, et al
    Strategies to Improve Exercise Adherence in Patients With Cirrhosis.
    Am J Gastroenterol. 2021 Jul 13. pii: 00000434-990000000-00043.
    PubMed    


  4. PINYOPORNPANISH K, Al-Yaman W, Butler RS, Carey W, et al
    Chemopreventive Effect of Statin on Hepatocellular Carcinoma in Patients With Nonalcoholic Steatohepatitis Cirrhosis.
    Am J Gastroenterol. 2021 Jul 2. pii: 00000434-990000000-00036.
    PubMed     Abstract available


    June 2021
  5. JINDAL A, Mukund A
    Management of Portal Vein Thrombosis in Cirrhosis-Need a Closer Look!
    Am J Gastroenterol. 2021 Jun 30. pii: 00000434-990000000-00025.
    PubMed    


  6. ZHAI LL, Tang ZG
    Effect of Vitamin D Supplementation on Vitamin D Level and Bone Mineral Density in Patients With Cirrhosis: Several Confounding Factors.
    Am J Gastroenterol. 2021 Jun 23. pii: 00000434-990000000-00016.
    PubMed    


  7. ACHARYA C, Nadhem O, Shaw J, Hassouneh R, et al
    Liver-Unrelated Comorbid Conditions Do Not Affect Cognitive Performance or Hepatic Encephalopathy Progression in Cirrhosis.
    Am J Gastroenterol. 2021 Jun 18. pii: 00000434-990000000-00012.
    PubMed     Abstract available


  8. LOUISSAINT J, May FP, Williams S, Tapper EB, et al
    Effective Mentorship as a Means to Recruit, Retain, and Promote Underrepresented Minorities in Academic Gastroenterology and Hepatology.
    Am J Gastroenterol. 2021;116:1110-1113.
    PubMed    


  9. CRAVEN LJ, Parvathy SN, Burton JP, Silverman MS, et al
    Response to Ianiro et al.
    Am J Gastroenterol. 2021;116:1361-1362.
    PubMed    


  10. IANIRO G, Porcari S, Gasbarrini A, Cammarota G, et al
    Quantity of Donor Stool for Fecal Microbiota Transplantation: The More, the Better?
    Am J Gastroenterol. 2021;116:1360-1361.
    PubMed    


  11. BENMASSAOUD A, Tsochatzis E
    Response to Debnath and Rathi.
    Am J Gastroenterol. 2021;116:1358-1359.
    PubMed    


  12. DEBNATH P, Rathi P
    Sarcopenia and TIPS: How Best to Measure Muscle Mass.
    Am J Gastroenterol. 2021;116:1358.
    PubMed    


  13. WU F, Pahkala K, Juonala M, Jaakkola J, et al
    Childhood and Adulthood Passive Smoking and Nonalcoholic Fatty Liver in Midlife: A 31-year Cohort Study.
    Am J Gastroenterol. 2021;116:1256-1263.
    PubMed     Abstract available


    May 2021
  14. HERNANDEZ-CONDE M, Llop E, Gomez-Pimpollo L, Fernandez Carrillo C, et al
    Adding Branched-Chain Amino Acids to an Enhanced Standard-of-Care Treatment Improves Muscle Mass of Cirrhotic Patients With Sarcopenia: A Placebo-Controlled Trial.
    Am J Gastroenterol. 2021 May 26. pii: 00000434-900000000-98756.
    PubMed     Abstract available


  15. FARUQUI S, Okoli FC, Olsen SK, Feldman DM, et al
    Cholangiopathy After Severe COVID-19: Clinical Features and Prognostic Implications.
    Am J Gastroenterol. 2021 May 17. pii: 00000434-900000000-98779.
    PubMed     Abstract available


  16. JOHN BV, Khakoo NS, Schwartz KB, Aitchenson G, et al
    Ursodeoxycholic Acid Response Is Associated With Reduced Mortality in Primary Biliary Cholangitis With Compensated Cirrhosis.
    Am J Gastroenterol. 2021 May 13. pii: 00000434-900000000-98782.
    PubMed     Abstract available


  17. WANG R, Yang L, Hu C, Yan J, et al
    A Tip of the Iceberg on the Mechanism of SARS-CoV-2-Induced Liver Injury.
    Am J Gastroenterol. 2021;116:1097-1098.
    PubMed    


  18. BENMASSAOUD A, Tsochatzis E
    Response to Anand and Sharma.
    Am J Gastroenterol. 2021;116:1094-1095.
    PubMed    


  19. BJORNSSON HK, Bjornsson ES
    Database Studies on Drug-Induced Liver Injury: The Importance of Causality Assessment.
    Am J Gastroenterol. 2021;116:1090-1091.
    PubMed    


  20. CHALASANI NP, Maddur H, Russo MW, Wong RJ, et al
    ACG Clinical Guideline: Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury.
    Am J Gastroenterol. 2021;116:878-898.
    PubMed     Abstract available


  21. VILAR-GOMEZ E, Pirola CJ, Sookoian S, Wilson LA, et al
    Impact of the Association Between PNPLA3 Genetic Variation and Dietary Intake on the Risk of Significant Fibrosis in Patients With NAFLD.
    Am J Gastroenterol. 2021;116:994-1006.
    PubMed     Abstract available


  22. YATACO ML, Bowman AW, Keaveny AP
    Management of the Incidental Liver Lesion.
    Am J Gastroenterol. 2021;116:855-861.
    PubMed    


  23. ESLAM M, Wong GL, Hashem AM, Chan HL, et al
    A Sequential Algorithm Combining ADAPT and Liver Stiffness Can Stage Metabolic-Associated Fatty Liver Disease in Hospital-Based and Primary Care Patients.
    Am J Gastroenterol. 2021;116:984-993.
    PubMed     Abstract available


    April 2021
  24. GROVER I, Gunjan D, Singh N, Benjamin J, et al
    Effect of Vitamin D Supplementation on Vitamin D Level and Bone Mineral Density in Patients With Cirrhosis: A Randomized Clinical Trial.
    Am J Gastroenterol. 2021 Apr 29. pii: 00000434-900000000-98797.
    PubMed     Abstract available


  25. TRAN S, Jeong D, Henry L, Cheung RC, et al
    Initial Evaluation, Long-Term Monitoring, and Hepatocellular Carcinoma Surveillance of Chronic Hepatitis B in Routine Practice: A Nationwide US Study.
    Am J Gastroenterol. 2021 Apr 29. pii: 00000434-900000000-98796.
    PubMed     Abstract available


  26. THORNTON C, Somayaji R, Parkins M, Swain MG, et al
    Characteristics and Outcomes of Children With Cystic Fibrosis Hospitalized With Cirrhosis in the United States.
    Am J Gastroenterol. 2021 Apr 29. pii: 00000434-900000000-98795.
    PubMed     Abstract available


  27. MA C, Qian AS, Nguyen NH, Stukalin I, et al
    Trends in the Economic Burden of Chronic Liver Diseases and Cirrhosis in the United States: 1996-2016.
    Am J Gastroenterol. 2021 Apr 28. doi: 10.14309/ajg.0000000000001292.
    PubMed     Abstract available


  28. KAWAGUCHI Y, Hasegawa K, Hagiwara Y, De Bellis M, et al
    Effect of Diameter and Number of Hepatocellular Carcinomas on Survival After Resection, Transarterial Chemoembolization, and Ablation.
    Am J Gastroenterol. 2021 Apr 21. pii: 00000434-900000000-98811.
    PubMed     Abstract available


  29. SERPER M, Reddy KR, Bewtra M, Ahmad N, et al
    COVID-19 Vaccine Perceptions Among Patients With Chronic Disease in a Large Gastroenterology and Hepatology Practice.
    Am J Gastroenterol. 2021 Apr 19. pii: 00000434-900000000-98813.
    PubMed     Abstract available


  30. SHARMA S, Saraya A
    Avoiding Beta Blockers in Patients of Hepatitis C Virus-Related Compensated Cirrhosis With Clinically Significant Portal Hypertension After Cure With Antivirals: Are We There Yet?
    Am J Gastroenterol. 2021 Apr 9. pii: 00000434-900000000-98829.
    PubMed    


  31. KHALILI M, Kleiner DE, King WC, Sterling RK, et al
    Hepatic Steatosis and Steatohepatitis in a Large North American Cohort of Adults With Chronic Hepatitis B.
    Am J Gastroenterol. 2021 Apr 8. pii: 00000434-900000000-98823.
    PubMed     Abstract available


  32. SONI D, Roy A, De A, Verma N, et al
    MASQ-HE: Unmasking the Predictors of Overt Hepatic Encephalopathy?
    Am J Gastroenterol. 2021;116:836-837.
    PubMed    


  33. MORTON A
    Measuring Serum Sodium in Cirrhosis: Regarding "Hyponatremia in Cirrhosis: An Update".
    Am J Gastroenterol. 2021;116:835.
    PubMed    


  34. PONS M, Augustin S, Scheiner B, Guillaume M, et al
    Noninvasive Diagnosis of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease.
    Am J Gastroenterol. 2021;116:723-732.
    PubMed     Abstract available


  35. LAI JC, Dodge JL, Kappus MR, Wong R, et al
    A Multicenter Pilot Randomized Clinical Trial of a Home-Based Exercise Program for Patients With Cirrhosis: The Strength Training Intervention (STRIVE).
    Am J Gastroenterol. 2021;116:717-722.
    PubMed     Abstract available


  36. KOTANI K, Uchida-Kobayashi S, Yoshida K, Kawamura E, et al
    Lenvatinib-Induced Tumor-Related Hemorrhage in Patients With Unresectable Hepatocellular Carcinoma.
    Am J Gastroenterol. 2021;116:631.
    PubMed    


  37. TAPPER EB
    Finding Common Ground With Our MASQs Off.
    Am J Gastroenterol. 2021;116:837.
    PubMed    


  38. ALUKAL JJ, Thuluvath PJ
    Reply to Morton.
    Am J Gastroenterol. 2021;116:835-836.
    PubMed    


  39. YAMADA G, Hagiwara Y, Kimura T, Takeuchi Y, et al
    Impact of Body Weight Gain on the Incidence of Nonalcoholic Fatty Liver Disease in Nonobese Japanese Individuals.
    Am J Gastroenterol. 2021;116:733-740.
    PubMed     Abstract available


  40. KOK B, McNeely M, Watt M, Tandon P, et al
    Exercise Only Works If You Do It! The Holy Grail of Adherence.
    Am J Gastroenterol. 2021;116:673-674.
    PubMed     Abstract available


    March 2021
  41. ROGAL S, Youk A, Agbalajobi O, Zhang H, et al
    Medication Treatment of Active Opioid Use Disorder in Veterans With Cirrhosis.
    Am J Gastroenterol. 2021 Mar 30. pii: 00000434-900000000-98834.
    PubMed     Abstract available


  42. AYOUB F, Ouni A, Case R, Ladna M, et al
    Dissemination of Gastroenterology and Hepatology Research on Social Media Platforms Is Associated With Increased Citation Count.
    Am J Gastroenterol. 2021 Mar 22. pii: 00000434-900000000-98848.
    PubMed     Abstract available


  43. JANSSON-KNODELL CL, Calderon G, Weber R, Ghabril M, et al
    Small Intestine Varices in Cirrhosis at a High-Volume Liver Transplant Center: A Retrospective Database Study and Literature Review.
    Am J Gastroenterol. 2021 Mar 10. pii: 00000434-900000000-98858.
    PubMed     Abstract available


  44. CHANDEL S, Singh V
    Hyponatremia in Cirrhosis: Role of Vasopressors.
    Am J Gastroenterol. 2021 Mar 10. pii: 00000434-900000000-98857.
    PubMed    


  45. NAM H, Lee SW, Kwon JH, Lee HL, et al
    Prediction of Hepatocellular Carcinoma by On-Therapy Response of Noninvasive Fibrosis Markers in Chronic Hepatitis B.
    Am J Gastroenterol. 2021 Mar 10. pii: 00000434-900000000-98856.
    PubMed     Abstract available


  46. GIL-GOMEZ A, Ampuero J, Rojas A, Gallego-Duran R, et al
    Development and Validation of a Clinical-Genetic Risk Score to Predict Hepatic Encephalopathy in Patients With Liver Cirrhosis.
    Am J Gastroenterol. 2021 Mar 2. pii: 00000434-900000000-98817.
    PubMed     Abstract available


  47. WONG RJ, Jain MK, Therapondos G, Niu B, et al
    Antiviral Therapy Reduces Risk of Cirrhosis in Noncirrhotic HBV Patients Among 4 Urban Safety-Net Health Systems.
    Am J Gastroenterol. 2021 Mar 1. pii: 00000434-900000000-98873.
    PubMed     Abstract available


  48. BRAILLON A
    Hepatocellular Carcinoma in Women: Could Tobacco Matter More than Sex?
    Am J Gastroenterol. 2021;116:617.
    PubMed    


  49. SUBRAMANIAM M, Azad N, Wasan SK, Long MT, et al
    Equal Opportunity: Women Representation on Editorial Boards and Authorship of Editorials in Gastroenterology and Hepatology Journals.
    Am J Gastroenterol. 2021;116:613-616.
    PubMed     Abstract available


  50. MONROSE E, Bui A, Rosenbluth E, Dickstein D, et al
    Burden of Future Liver Abnormalities in Patients With Intrahepatic Cholestasis of Pregnancy.
    Am J Gastroenterol. 2021;116:568-575.
    PubMed     Abstract available


  51. SHAUKAT A, Oxentenko AS
    The Time Is Now to Understand and Address Sex-Related Disparities in Gastroenterology and Hepatology.
    Am J Gastroenterol. 2021;116:441-443.
    PubMed     Abstract available


  52. PHIPPS M, Wattacheril J
    Response to Braillon.
    Am J Gastroenterol. 2021;116:617-618.
    PubMed    


  53. VALENTIN N, Guerrido I, Rozenshteyn F, Pinotti R, et al
    Pregnancy Outcomes After Liver Transplantation: A Systematic Review and Meta-Analysis.
    Am J Gastroenterol. 2021;116:491-504.
    PubMed     Abstract available


    February 2021
  54. BAJAJ JS
    The Three Villages of Hepatic Encephalopathy.
    Am J Gastroenterol. 2021 Feb 26. pii: 00000434-900000000-98870.
    PubMed     Abstract available


  55. LV Y, Bai W, Li K, Wang Z, et al
    Anticoagulation and Transjugular Intrahepatic Portosystemic Shunt for the Management of Portal Vein Thrombosis in Cirrhosis: A Prospective Observational Study.
    Am J Gastroenterol. 2021 Feb 25. pii: 00000434-900000000-98874.
    PubMed     Abstract available


  56. TOSETTI G, Degasperi E, Farina E, D'Ambrosio R, et al
    Decompensation in Direct-Acting Antiviral Cured Hepatitis C Virus Compensated Patients With Clinically Significant Portal Hypertension: Too Rare to Warrant Universal Beta-Blocker Therapy.
    Am J Gastroenterol. 2021 Feb 18. pii: 00000434-900000000-98881.
    PubMed     Abstract available


  57. TAN HK, Teng MLP, Soh AYS, Cheo SHY, et al
    Poor Outcomes of Cirrhosis due to Nonalcoholic Steatohepatitis Compared With Hepatitis B After Decompensation With Ascites.
    Am J Gastroenterol. 2021 Feb 1. doi: 10.14309/ajg.0000000000001176.
    PubMed     Abstract available


    January 2021
  58. SAWAS T, Dilmaghani S, Dhaliwal L, Wang KK, et al
    Risk Factor Profiles Can Distinguish Esophageal Adenocarcinoma From Barrett's Esophagus.
    Am J Gastroenterol. 2021;116:198-201.
    PubMed     Abstract available


  59. LEE JI, Lee HW, Lee KS, Lee HS, et al
    Effects of Statin Use on the Development and Progression of Nonalcoholic Fatty Liver Disease: A Nationwide Nested Case-Control Study.
    Am J Gastroenterol. 2021;116:116-124.
    PubMed     Abstract available


    December 2020
  60. LAI JC, Dodge JL, Kappus MR, Wong R, et al
    A Multicenter Pilot Randomized Clinical Trial of a Home-Based Exercise Program for Patients With Cirrhosis: The Strength Training Intervention (STRIVE).
    Am J Gastroenterol. 2020;Publish Ahead of Print.
    PubMed     Abstract available


  61. YOUNOSSI ZM, Noureddin M, Bernstein D, Kwo P, et al
    Role of Noninvasive Tests in Clinical Gastroenterology Practices to Identify Patients With Nonalcoholic Steatohepatitis at High Risk of Adverse Outcomes: Expert Panel Recommendations.
    Am J Gastroenterol. 2020 Dec 7. doi: 10.14309/ajg.0000000000001054.
    PubMed     Abstract available


    November 2020
  62. KIM NJ, Jacob DA, Ioannou GN, John BV, et al
    Rates and Predictors of Undergoing Different Hepatocellular Carcinoma Screening Tests in Patients With Cirrhosis.
    Am J Gastroenterol. 2020 Nov 26. doi: 10.14309/ajg.0000000000001000.
    PubMed     Abstract available


  63. SHARMA S, Agarwal S, Anand A
    Noninvasive Diagnosis of Clinically Significant Portal Hypertension in Patients With Compensated Liver Disease: Whom and How to Screen?
    Am J Gastroenterol. 2020 Nov 23. doi: 10.14309/ajg.0000000000001078.
    PubMed    


  64. ANAND A, Sharma S
    Sarcopenia Does Not Worsen Outcomes in Patients With Refractory Ascites Under Transjugular Intrahepatic Portosystemic Shunt Placement-Preliminary Evidence?
    Am J Gastroenterol. 2020 Nov 10. doi: 10.14309/ajg.0000000000001053.
    PubMed    


  65. BENMASSAOUD A, Roccarina D, Arico F, Leandro G, et al
    Sarcopenia Does Not Worsen Survival in Patients With Cirrhosis Undergoing Transjugular Intrahepatic Portosystemic Shunt for Refractory Ascites.
    Am J Gastroenterol. 2020;115:1911-1914.
    PubMed     Abstract available


  66. CHEDID VG, Kamath AA, M Knudsen J, Frimannsdottir K, et al
    Three-Dimensional-Printed Liver Model Helps Learners Identify Hepatic Subsegments: A Randomized-Controlled Cross-Over Trial.
    Am J Gastroenterol. 2020;115:1906-1910.
    PubMed     Abstract available


  67. ARE VS, Knapp SM, Banerjee A, Shamseddeen H, et al
    Improving Outcomes of Bariatric Surgery in Patients With Cirrhosis in the United States: A Nationwide Assessment.
    Am J Gastroenterol. 2020;115:1849-1856.
    PubMed     Abstract available


  68. ALUKAL JJ, John S, Thuluvath PJ
    Hyponatremia in Cirrhosis: An Update.
    Am J Gastroenterol. 2020;115:1775-1785.
    PubMed     Abstract available


  69. AHMED O, Pillai A
    Hepatocellular Carcinoma: A Contemporary Approach to Locoregional Therapy.
    Am J Gastroenterol. 2020;115:1733-1736.
    PubMed    


    October 2020
  70. LIU W, Wang S, Guo J, Liu X, et al
    A Bolt Method of Treating the Stent Migration After Endoscopic Ultrasound-Guided Hepaticogastrostomy.
    Am J Gastroenterol. 2020 Oct 28. doi: 10.14309/ajg.0000000000000938.
    PubMed    


  71. LEE BP, Dodge JL, Terrault NA
    Excess Mortality After Liver Transplantation in Young Women With Alcohol-Associated Liver Disease.
    Am J Gastroenterol. 2020 Oct 28. doi: 10.14309/ajg.0000000000001007.
    PubMed     Abstract available


  72. THULUVATH PJ, To C, Amjad W
    Role of Locoregional Therapies in Patients With Hepatocellular Cancer Awaiting Liver Transplantation.
    Am J Gastroenterol. 2020 Oct 23. doi: 10.14309/ajg.0000000000000999.
    PubMed     Abstract available


  73. MORTON A
    Measuring Serum Sodium in Cirrhosis: Regarding "Hyponatremia in Cirrhosis: An Update".
    Am J Gastroenterol. 2020 Oct 19. doi: 10.14309/ajg.0000000000001011.
    PubMed    


  74. SONI D, Roy A, De A, Verma N, et al
    MASQ-HE: Unmasking the Predictors of Overt Hepatic Encephalopathy?
    Am J Gastroenterol. 2020 Oct 19. doi: 10.14309/ajg.0000000000001010.
    PubMed    


  75. ARE VS, Knapp SM, Banerjee A, Shamseddeen H, et al
    Improving Outcomes of Bariatric Surgery in Patients With Cirrhosis in the United States: A Nationwide Assessment.
    Am J Gastroenterol. 2020 Oct 19. doi: 10.14309/ajg.0000000000000911.
    PubMed     Abstract available


  76. KIM JH, Kim DJ, Kwon CI
    Pseudoaneurysmal Rupture of the Hepatic Artery Caused by a Biliary Plastic Stent.
    Am J Gastroenterol. 2020 Oct 15. doi: 10.14309/ajg.0000000000000982.
    PubMed    


  77. REIG A, Norman GL, Pares A
    Surrogate Markers for Antimitochondrial Antibody Negative Primary Biliary Cholangitis.
    Am J Gastroenterol. 2020 Oct 15. doi: 10.14309/ajg.0000000000000980.
    PubMed    


  78. OZDOGAN E, Doganay L, Can D, Arikan C, et al
    Disease Course and Treatment Response of Eosinophilic Gastrointestinal Diseases in Children With Liver Transplantation: Long-Term Follow-Up.
    Am J Gastroenterol. 2020 Oct 13. doi: 10.14309/ajg.0000000000000934.
    PubMed     Abstract available


  79. BENMASSAOUD A, Roccarina D, Arico F, Leandro G, et al
    Sarcopenia Does Not Worsen Survival in Patients With Cirrhosis Undergoing Transjugular Intrahepatic Portosystemic Shunt for Refractory Ascites.
    Am J Gastroenterol. 2020 Oct 12. doi: 10.14309/ajg.0000000000000959.
    PubMed     Abstract available


  80. HU C, Anjur V, Saboo K, Reddy KR, et al
    Low Predictability of Readmissions and Death Using Machine Learning in Cirrhosis.
    Am J Gastroenterol. 2020 Oct 8. doi: 10.14309/ajg.0000000000000971.
    PubMed     Abstract available


  81. PILLAI A, Ahn J, Kulik L
    Integrating Genomics Into Clinical Practice in Hepatocellular Carcinoma: The Challenges Ahead.
    Am J Gastroenterol. 2020 Oct 8. doi: 10.14309/ajg.0000000000000843.
    PubMed     Abstract available


  82. PONS M, Augustin S, Scheiner B, Guillaume M, et al
    Noninvasive Diagnosis of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease.
    Am J Gastroenterol. 2020 Oct 8. doi: 10.14309/ajg.0000000000000994.
    PubMed     Abstract available


  83. KALAMBOKIS GN, Tsiakas I, Filippas-Ntekuan S, Christaki M, et al
    Empagliflozin Eliminates Refractory Ascites and Hepatic Hydrothorax in a Patient With Primary Biliary Cirrhosis.
    Am J Gastroenterol. 2020 Oct 7. doi: 10.14309/ajg.0000000000000995.
    PubMed    


  84. CHEN PT, Tzeng HL, Wang HP, Liu KL, et al
    Caput Medusae Bleeding.
    Am J Gastroenterol. 2020;115:1570.
    PubMed    


    September 2020
  85. AHMED O, Pillai A
    Hepatocellular Carcinoma: A Contemporary Approach to Locoregional Therapy.
    Am J Gastroenterol. 2020 Sep 30. doi: 10.14309/ajg.0000000000000931.
    PubMed    


  86. GRANITO A, Muratori L, Tovoli F, Muratori P, et al
    Surrogate Markers for Antimitochondrial Antibody-Negative Primary Biliary Cholangitis.
    Am J Gastroenterol. 2020 Sep 28. doi: 10.14309/ajg.0000000000000928.
    PubMed    


  87. WONG RJ, Saab S, Konyn P, Sundaram V, et al
    Rural-Urban Geographical Disparities in Hepatocellular Carcinoma Incidence Among US Adults, 2004-2017.
    Am J Gastroenterol. 2020 Sep 24. doi: 10.14309/ajg.0000000000000948.
    PubMed     Abstract available


  88. CHEDID VG, Kamath AA, M Knudsen J, Frimannsdottir K, et al
    Three-Dimensional-Printed Liver Model Helps Learners Identify Hepatic Subsegments: A Randomized-Controlled Cross-Over Trial.
    Am J Gastroenterol. 2020 Sep 24. doi: 10.14309/ajg.0000000000000958.
    PubMed     Abstract available


  89. CARBALLO-FOLGOSO L, Alvarez-Navascues C, Rodriguez M
    Acute Liver Failure Associated With Ulipristal Acetate: A Case Report.
    Am J Gastroenterol. 2020;115:1542-1544.
    PubMed    


  90. KIM D, Vazquez-Montesino LM, Escober JA, Fernandes CT, et al
    Low Thyroid Function in Nonalcoholic Fatty Liver Disease Is an Independent Predictor of All-Cause and Cardiovascular Mortality.
    Am J Gastroenterol. 2020;115:1496-1504.
    PubMed     Abstract available


  91. ZHAO J, Blais JE, Chui CSL, Suh IH, et al
    Association Between Nonvitamin K Antagonist Oral Anticoagulants or Warfarin and Liver Injury: A Cohort Study.
    Am J Gastroenterol. 2020;115:1513-1524.
    PubMed     Abstract available


    August 2020
  92. WHITFIELD JB, Masson S, Liangpunsakul S, Mueller S, et al
    Obesity, Diabetes, Coffee, Tea, and Cannabis Use Alter Risk for Alcohol-Related Cirrhosis in 2 Large Cohorts of High-Risk Drinkers.
    Am J Gastroenterol. 2020 Aug 31. doi: 10.14309/ajg.0000000000000833.
    PubMed     Abstract available


  93. CAO Z, Liu Y, Cai M, Xu Y, et al
    The Use of NACSELD and EASL-CLIF Classification Systems of ACLF in the Prediction of Prognosis in Hospitalized Patients With Cirrhosis.
    Am J Gastroenterol. 2020 Aug 27. doi: 10.14309/ajg.0000000000000771.
    PubMed     Abstract available


  94. YE L, Zhang C, Seidensticker M, Mayerle J, et al
    Durable Complete Response of Brain Metastasis From Hepatocellular Carcinoma On Treatment With Nivolumab and Radiation Treatment.
    Am J Gastroenterol. 2020 Aug 26. doi: 10.14309/ajg.0000000000000800.
    PubMed    


  95. LOPEZ-TOBARUELA JM, Valverde-Lopez F, Lopez de Hierro-Ruiz M, Redondo-Cerezo E, et al
    Hepatic Abscess After Biodegradable Esophageal Stent Placement: A Rare Complication.
    Am J Gastroenterol. 2020 Aug 19. doi: 10.14309/ajg.0000000000000821.
    PubMed    


  96. TAPPER EB, Zhao L, Nikirk S, Baki J, et al
    Incidence and Bedside Predictors of the First Episode of Overt Hepatic Encephalopathy in Patients With Cirrhosis.
    Am J Gastroenterol. 2020 Aug 6. doi: 10.14309/ajg.0000000000000762.
    PubMed     Abstract available


  97. ALUKAL JJ, John S, Thuluvath PJ
    Hyponatremia in Cirrhosis: An Update.
    Am J Gastroenterol. 2020 Aug 6. doi: 10.14309/ajg.0000000000000786.
    PubMed     Abstract available


  98. REVERTER E, Ott P
    Compensated Cirrhosis and 20 mm Hg: A Point of No Return?
    Am J Gastroenterol. 2020 Aug 5. doi: 10.14309/ajg.0000000000000770.
    PubMed     Abstract available


  99. ZHANG X, Tang C, Tian D, Hou X, et al
    Management of Digestive Disorders and Procedures Associated With COVID-19.
    Am J Gastroenterol. 2020;115:1153-1155.
    PubMed    


  100. YOUNES R, Govaere O, Petta S, Miele L, et al
    Presence of Serum Antinuclear Antibodies Does Not Impact Long-Term Outcomes in Nonalcoholic Fatty Liver Disease.
    Am J Gastroenterol. 2020;115:1289-1292.
    PubMed     Abstract available


    July 2020
  101. SAMOYLOVA ML, Kapila N, McElroy L, Suhocki P, et al
    Gastrohepatic Fistula After Y-90 Embolization of Hepatocellular Carcinoma.
    Am J Gastroenterol. 2020 Jul 31. doi: 10.14309/ajg.0000000000000793.
    PubMed    


  102. LEVY C, Bowlus CL
    Role of Antinuclear Antibodies in Primary Biliary Cholangitis.
    Am J Gastroenterol. 2020 Jul 22. doi: 10.14309/ajg.0000000000000765.
    PubMed     Abstract available


  103. GAO F, Zheng KI, Fan YC, Targher G, et al
    ACE2: A Linkage for the Interplay Between COVID-19 and Decompensated Cirrhosis.
    Am J Gastroenterol. 2020 Jul 16. doi: 10.14309/ajg.0000000000000780.
    PubMed    


  104. KOTANI K, Uchida-Kobayashi S, Yoshida K, Kawamura E, et al
    Lenvatinib-Induced Tumor-Related Hemorrhage in Patients With Unresectable Hepatocellular Carcinoma.
    Am J Gastroenterol. 2020 Jul 14. doi: 10.14309/ajg.0000000000000747.
    PubMed    


  105. RUBIN JN, Gilman CAL, Gasmi B, Stern WR, et al
    Hepatocellular Carcinoma Where You Least Expect It.
    Am J Gastroenterol. 2020;115:1134-1136.
    PubMed    


  106. BAJAJ JS, Brenner DM, Cai Q, Cash BD, et al
    Major Trends in Gastroenterology and Hepatology Between 2010 and 2019: An Overview of Advances From the Past Decade Selected by the Editorial Board of The American Journal of Gastroenterology.
    Am J Gastroenterol. 2020;115:1007-1018.
    PubMed    


  107. BAJAJ JS, Lauridsen M, Tapper EB, Duarte-Rojo A, et al
    Important Unresolved Questions in the Management of Hepatic Encephalopathy: An ISHEN Consensus.
    Am J Gastroenterol. 2020;115:989-1002.
    PubMed     Abstract available


  108. BOWER RJ, Frenette C
    Reevaluating Goals of Therapy in Primary Biliary Cholangitis: Is Good Enough Is Not Good Enough Anymore?
    Am J Gastroenterol. 2020;115:1024-1025.
    PubMed     Abstract available


  109. CRAVEN L, Rahman A, Nair Parvathy S, Beaton M, et al
    Allogenic Fecal Microbiota Transplantation in Patients With Nonalcoholic Fatty Liver Disease Improves Abnormal Small Intestinal Permeability: A Randomized Control Trial.
    Am J Gastroenterol. 2020;115:1055-1065.
    PubMed     Abstract available


    June 2020
  110. BAJAJ JS, Brenner DM, Cai Q, Cash BD, et al
    Major Trends in Gastroenterology and Hepatology Between 2010 and 2019: An Overview of Advances From the Past Decade Selected by the Editorial Board of The American Journal of Gastroenterology.
    Am J Gastroenterol. 2020 Jun 23. doi: 10.14309/ajg.0000000000000709.
    PubMed    


  111. PARIKH ND, Singal AG, Hutton DW, Tapper EB, et al
    Cost-Effectiveness of Hepatocellular Carcinoma Surveillance: An Assessment of Benefits and Harms.
    Am J Gastroenterol. 2020 Jun 9. doi: 10.14309/ajg.0000000000000715.
    PubMed     Abstract available


  112. KOSHY AN, Farouque O, Gow PJ
    Response to Singh, et al.
    Am J Gastroenterol. 2020;115:951-952.
    PubMed    


  113. MANCUSO A, Amata M, Politi F, Mitra M, et al
    Controversies in Budd-Chiari Syndrome Management: Potential Role of Liver Stiffness.
    Am J Gastroenterol. 2020;115:952-953.
    PubMed    


  114. SAAB S, Kim NG, Lee EW
    Practical Tips on TIPS: When and When Not to Request It.
    Am J Gastroenterol. 2020;115:797-800.
    PubMed    


  115. XU L, Xie J, Chen S, Chen Y, et al
    Light-to-Moderate Alcohol Consumption Is Associated With Increased Risk of Type 2 Diabetes in Individuals With Nonalcoholic Fatty Liver Disease: A Nine-Year Cohort Study.
    Am J Gastroenterol. 2020;115:876-884.
    PubMed     Abstract available


    May 2020
  116. REIG A, Norman GL, Garcia M, Shums Z, et al
    Novel Anti-Hexokinase 1 Antibodies Are Associated With Poor Prognosis in Patients With Primary Biliary Cholangitis.
    Am J Gastroenterol. 2020 May 27. doi: 10.14309/ajg.0000000000000690.
    PubMed     Abstract available


  117. PHIPPS M, Livanos A, Guo A, Pomenti S, et al
    Gender Matters: Characteristics of Hepatocellular Carcinoma in Women From a Large, Multicenter Study in the United States.
    Am J Gastroenterol. 2020 May 22. doi: 10.14309/ajg.0000000000000643.
    PubMed     Abstract available


  118. JINDAL A, Bhardwaj A, Kumar G, Sarin SK, et al
    Clinical Decompensation and Outcomes in Patients With Compensated Cirrhosis and a Hepatic Venous Pressure Gradient >/=20 mm Hg.
    Am J Gastroenterol. 2020 May 21. doi: 10.14309/ajg.0000000000000653.
    PubMed     Abstract available


  119. PATIDAR KR, Shamseddeen H, Xu C, Ghabril MS, et al
    Hospital-Acquired Versus Community-Acquired Acute Kidney Injury in Patients With Cirrhosis: A Prospective Study.
    Am J Gastroenterol. 2020 May 5. doi: 10.14309/ajg.0000000000000670.
    PubMed     Abstract available


  120. VIJAYARAGHAVAN R, Jindal A, Arora V, Choudhary A, et al
    Hemodynamic Effects of Adding Simvastatin to Carvedilol for Primary Prophylaxis of Variceal Bleeding: A Randomized Controlled Trial.
    Am J Gastroenterol. 2020;115:729-737.
    PubMed     Abstract available


    April 2020
  121. RUBIN JN, Gilman CAL, Gasmi B, Stern WR, et al
    Hepatocellular Carcinoma Where You Least Expect It.
    Am J Gastroenterol. 2020 Apr 10. doi: 10.14309/ajg.0000000000000616.
    PubMed    


  122. MOON AM, Kim HP, Barritt AS 4th, Darling J, et al
    A Quality Improvement Initiative Results in Improved Rates of Timely Postvariceal Bleeding Surveillance Endoscopy.
    Am J Gastroenterol. 2020;115:625-628.
    PubMed     Abstract available


  123. HAN E, Lee YH, Kim YD, Kim BK, et al
    Nonalcoholic Fatty Liver Disease and Sarcopenia Are Independently Associated With Cardiovascular Risk.
    Am J Gastroenterol. 2020;115:584-595.
    PubMed     Abstract available


    March 2020
  124. SALIM TI, Nestlerode LC, Lucatorto EL, Wasserman TL, et al
    Frailty as Tested by Gait Speed Is a Risk Factor for Liver Transplant Respiratory Complications.
    Am J Gastroenterol. 2020 Mar 31. doi: 10.14309/ajg.0000000000000609.
    PubMed     Abstract available


  125. BAJAJ JS, Lauridsen M, Tapper EB, Duarte-Rojo A, et al
    Important Unresolved Questions in the Management of Hepatic Encephalopathy: An ISHEN Consensus.
    Am J Gastroenterol. 2020 Mar 30. doi: 10.14309/ajg.0000000000000603.
    PubMed     Abstract available


  126. KAPILA N, Dorsey YC, Shah J, King L, et al
    Transjugular Intrahepatic Portosystemic Shunt for a Challenging Pregnancy.
    Am J Gastroenterol. 2020 Mar 26. doi: 10.14309/ajg.0000000000000602.
    PubMed    


  127. LEE JK, Merchant SA, Schneider JL, Jensen CD, et al
    Proton Pump Inhibitor Use and Risk of Gastric, Colorectal, Liver, and Pancreatic Cancers in a Community-Based Population.
    Am J Gastroenterol. 2020 Mar 20. doi: 10.14309/ajg.0000000000000591.
    PubMed     Abstract available


  128. CHAN TT, Chan WK, Wong GL, Chan AW, et al
    Positive Hepatitis B Core Antibody Is Associated With Cirrhosis and Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease.
    Am J Gastroenterol. 2020 Mar 9. doi: 10.14309/ajg.0000000000000588.
    PubMed     Abstract available


    February 2020
  129. KOK B, Whitlock R, Ferguson T, Kowalczewski J, et al
    Health-Related Quality of Life: A Rapid Predictor of Hospitalization in Patients With Cirrhosis.
    Am J Gastroenterol. 2020 Feb 20. doi: 10.14309/ajg.0000000000000545.
    PubMed     Abstract available


  130. PERRY LM, Pan D, Loehfelm TW, Tejaswi S, et al
    Pancreaticoportal Fistula Causing Hepatic Necrosis Treated With Pancreatic Duct Stenting.
    Am J Gastroenterol. 2020 Feb 12. doi: 10.14309/ajg.0000000000000554.
    PubMed    


  131. SINGH AD, Aggarwal M, Gupta S
    Heart of the Hepatorenal Matter!
    Am J Gastroenterol. 2020 Feb 5. doi: 10.14309/ajg.0000000000000547.
    PubMed    


  132. DAI C, Jiang M
    Women With Nonalcoholic Fatty Liver Disease Lose Protection Against Cardiovascular Disease?
    Am J Gastroenterol. 2020;115:303-304.
    PubMed    


  133. MILLER ED, Abu-Sbeih H, Styskel B, Nogueras Gonzalez GM, et al
    Clinical Characteristics and Adverse Impact of Hepatotoxicity due to Immune Checkpoint Inhibitors.
    Am J Gastroenterol. 2020;115:251-261.
    PubMed     Abstract available


    January 2020
  134. GORDON SC, Wu KH, Lindor K, Bowlus CL, et al
    Ursodeoxycholic Acid Treatment Preferentially Improves Overall Survival Among African Americans With Primary Biliary Cholangitis.
    Am J Gastroenterol. 2020 Jan 27. doi: 10.14309/ajg.0000000000000512.
    PubMed     Abstract available


  135. HSU YC, Nguyen MH
    Inhibitory Effect of Nucleos(t)ide Analogs on Telomerase Activity and Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B.
    Am J Gastroenterol. 2020 Jan 6. doi: 10.14309/ajg.0000000000000507.
    PubMed    


  136. CHOI J, Kim GA, Han S, Lim YS, et al
    Earlier Alanine Aminotransferase Normalization During Antiviral Treatment Is Independently Associated With Lower Risk of Hepatocellular Carcinoma in Chronic Hepatitis B.
    Am J Gastroenterol. 2020 Jan 2. doi: 10.14309/ajg.0000000000000490.
    PubMed     Abstract available


  137. SIMONETTO DA, Singal AK, Garcia-Tsao G, Caldwell SH, et al
    ACG Clinical Guideline: Disorders of the Hepatic and Mesenteric Circulation.
    Am J Gastroenterol. 2020;115:18-40.
    PubMed     Abstract available


  138. KLOMPENHOUWER AJ, Alblas M, van Rosmalen BV, Haring MPD, et al
    Response to Chen et al.
    Am J Gastroenterol. 2020;115:147-148.
    PubMed    


  139. MOON AM, Yang JY, Barritt AS 4th, Bataller R, et al
    Rising Mortality From Alcohol-Associated Liver Disease in the United States in the 21st Century.
    Am J Gastroenterol. 2020;115:79-87.
    PubMed     Abstract available


  140. SINGAL AK, Arora S, Wong RJ, Satapathy SK, et al
    Increasing Burden of Acute-On-Chronic Liver Failure Among Alcohol-Associated Liver Disease in the Young Population in the United States.
    Am J Gastroenterol. 2020;115:88-95.
    PubMed     Abstract available


  141. DANG K, Hirode G, Singal AK, Sundaram V, et al
    Alcoholic Liver Disease Epidemiology in the United States: A Retrospective Analysis of 3 US Databases.
    Am J Gastroenterol. 2020;115:96-104.
    PubMed     Abstract available


    December 2019
  142. ARSLAN F, Vahaboglu H
    Tenofovir for the Prevention of HCC in Patients With Cirrhosis.
    Am J Gastroenterol. 2019 Dec 16. doi: 10.14309/ajg.0000000000000477.
    PubMed    


  143. GORDON S, Fraysse J, Li S, Ozbay AB, et al
    Disease Severity Is Associated With Higher Healthcare Utilization in Nonalcoholic Steatohepatitis Medicare Patients.
    Am J Gastroenterol. 2019 Dec 12. doi: 10.14309/ajg.0000000000000484.
    PubMed     Abstract available


  144. PISCAGLIA F, Benevento F, Pecorell A, Forgione A, et al
    Anticoagulation in Cirrhotic Portal Vein Thrombosis: No Harm, but Survival Benefit Still Unclear.
    Am J Gastroenterol. 2019 Dec 5. doi: 10.14309/ajg.0000000000000483.
    PubMed    


    November 2019
  145. KOSHY AN, Farouque O, Cailes B, Testro A, et al
    Impaired Cardiac Reserve on Dobutamine Stress Echocardiography Predicts the Development of Hepatorenal Syndrome.
    Am J Gastroenterol. 2019 Nov 15. doi: 10.14309/ajg.0000000000000462.
    PubMed     Abstract available


  146. CAZZAGON N, Lemoinne S, El Mouhadi S, Trivedi PJ, et al
    The Complementary Value of Magnetic Resonance Imaging and Vibration-Controlled Transient Elastography for Risk Stratification in Primary Sclerosing Cholangitis.
    Am J Gastroenterol. 2019 Nov 14. doi: 10.14309/ajg.0000000000000461.
    PubMed     Abstract available


  147. KOWDLEY KV, Brown KE, Ahn J, Sundaram V, et al
    Correction: ACG Clinical Guideline: Hereditary Hemochromatosis.
    Am J Gastroenterol. 2019 Nov 11. doi: 10.14309/ajg.0000000000000469.
    PubMed    


  148. TAPPER EB, Rahimi RS
    Low-Value Levels: Ammonia Testing Does Not Improve the Outcomes of Overt Hepatic Encephalopathy.
    Am J Gastroenterol. 2019 Nov 8. doi: 10.14309/ajg.0000000000000454.
    PubMed     Abstract available


  149. GALLEGOS-OROZCO JF
    The Growing Challenge of Advanced Liver Disease Due to Alcohol Use in the United States.
    Am J Gastroenterol. 2019;114:1712-1713.
    PubMed     Abstract available


  150. YOUNOSSI ZM, Henry L
    The Impact of Obesity and Type 2 Diabetes on Chronic Liver Disease.
    Am J Gastroenterol. 2019;114:1714-1715.
    PubMed     Abstract available


  151. ALLEN AM, Therneau TM, Mara KC, Larson JJ, et al
    Women With Nonalcoholic Fatty Liver Disease Lose Protection Against Cardiovascular Disease: A Longitudinal Cohort Study.
    Am J Gastroenterol. 2019;114:1764-1771.
    PubMed     Abstract available


  152. HARRIS R, Card TR, Delahooke T, Aithal GP, et al
    Obesity Is the Most Common Risk Factor for Chronic Liver Disease: Results From a Risk Stratification Pathway Using Transient Elastography.
    Am J Gastroenterol. 2019;114:1744-1752.
    PubMed     Abstract available


    October 2019
  153. LUO X, Sui J, Yang W, Sun Q, et al
    Type 2 Diabetes Prevention Diet and Hepatocellular Carcinoma Risk in US Men and Women.
    Am J Gastroenterol. 2019 Oct 30. doi: 10.14309/ajg.0000000000000450.
    PubMed     Abstract available



  154. Correction: 18th International Society for Hepatic Encephalopathy and Nitrogen Metabolism Meeting Abstracts.
    Am J Gastroenterol. 2019 Oct 14. doi: 10.14309/ajg.0000000000000431.
    PubMed    


  155. HAJ M, Rockey DC
    Ammonia Levels Do Not Guide Clinical Management of Patients With Hepatic Encephalopathy Caused by Cirrhosis.
    Am J Gastroenterol. 2019 Oct 14. doi: 10.14309/ajg.0000000000000343.
    PubMed     Abstract available


  156. HSU YC, Wong GL, Chen CH, Peng CY, et al
    Tenofovir Versus Entecavir for Hepatocellular Carcinoma Prevention in an International Consortium of Chronic Hepatitis B.
    Am J Gastroenterol. 2019 Oct 11. pii: 00000434-900000000-00005.
    PubMed     Abstract available


  157. CHEN HL, Song YP, Liu K
    Model to Predict Regression of Large-Size Hepatocellular Adenoma: More Information Needed.
    Am J Gastroenterol. 2019 Oct 2. doi: 10.14309/ajg.0000000000000403.
    PubMed    


    September 2019
  158. GAWRIEH S, Wilson LA, Cummings OW, Clark JM, et al
    Histologic Findings of Advanced Fibrosis and Cirrhosis in Patients With Nonalcoholic Fatty Liver Disease Who Have Normal Aminotransferase Levels.
    Am J Gastroenterol. 2019 Sep 11. doi: 10.14309/ajg.0000000000000388.
    PubMed     Abstract available


  159. EFE C, Tascilar K, Montano-Loza AJ, Yoshida EM, et al
    Application of Risk Scores in the Daily Management of Primary Biliary Cholangitis: Response to Corpechot and Chazouilleres.
    Am J Gastroenterol. 2019 Sep 10. doi: 10.14309/ajg.0000000000000391.
    PubMed    


  160. KHANDWALA K, Ahmed A, Abid S
    Migration of Fish Bone Into the Portal Vein Resulting in Pylephlebitis and Pyogenic Liver Abscesses.
    Am J Gastroenterol. 2019;114:1414.
    PubMed    


  161. XIE K, Chen CH, Tsai SP, Lu PJ, et al
    Loss of Life Expectancy by 10 Years or More From Elevated Aspartate Aminotransferase: Finding Aspartate Aminotransferase a Better Mortality Predictor for All-Cause and Liver-Related than Alanine Aminotransferase.
    Am J Gastroenterol. 2019;114:1478-1487.
    PubMed     Abstract available


    August 2019
  162. HENRY Z
    Readmissions for Cirrhosis Within the Healthcare Readmissions Reduction Program: A Hidden Challenge.
    Am J Gastroenterol. 2019 Aug 23. doi: 10.14309/ajg.0000000000000368.
    PubMed     Abstract available


  163. BAJAJ JS, Bloom PP, Chung RT, Hassanein TI, et al
    Variability and Lability of Ammonia Levels in Healthy Volunteers and Patients With Cirrhosis: Implications for Trial Design and Clinical Practice.
    Am J Gastroenterol. 2019 Aug 21. doi: 10.14309/ajg.0000000000000384.
    PubMed     Abstract available


  164. YOUNOSSI ZM, Stepanova M, Lawitz EJ, Reddy KR, et al
    Patients With Nonalcoholic Steatohepatitis Experience Severe Impairment of Health-Related Quality of Life.
    Am J Gastroenterol. 2019 Aug 20. doi: 10.14309/ajg.0000000000000375.
    PubMed     Abstract available


  165. ROERECKE M, Vafaei A, Hasan OSM, Chrystoja BR, et al
    Alcohol Consumption and Risk of Liver Cirrhosis: A Systematic Review and Meta-Analysis.
    Am J Gastroenterol. 2019 Aug 20. doi: 10.14309/ajg.0000000000000340.
    PubMed     Abstract available


  166. CORPECHOT C, Chazouilleres O
    A Brief Reflection on Continuous vs Binary Risk Indicators in Primary Biliary Cholangitis.
    Am J Gastroenterol. 2019 Aug 14. doi: 10.14309/ajg.0000000000000360.
    PubMed    


  167. CARRION AF, Martin P
    Renal Dysfunction in Cirrhotic Patients.
    Am J Gastroenterol. 2019 Aug 7. doi: 10.14309/ajg.0000000000000355.
    PubMed    


  168. CHAK EW
    Anticoagulation of Portal Vein Thrombosis in Cirrhosis: First, Do No Harm.
    Am J Gastroenterol. 2019 Aug 2. doi: 10.14309/ajg.0000000000000351.
    PubMed    


  169. OKAFOR PN, Nnadi AK, Okoli O, Huang AE, et al
    Response to Rosenblatt et al.
    Am J Gastroenterol. 2019;114:1357-1358.
    PubMed    


  170. MENDEZ-SANCHEZ N, Qi X, Vitek L, Arrese M, et al
    Evaluating an Outpatient With an Elevated Bilirubin.
    Am J Gastroenterol. 2019;114:1185-1188.
    PubMed    


  171. GERHARDT F, Benesic A, Tillmann HL, Rademacher S, et al
    Iberogast-Induced Acute Liver Failure-Reexposure and In Vitro Assay Support Causality.
    Am J Gastroenterol. 2019;114:1358-1359.
    PubMed    


    July 2019
  172. RACHO RG, Krishna M, Canabal JM, Keaveny AP, et al
    Liver Transplantation for Acute Liver Failure Secondary to Acute Sickle Intrahepatic Cholestasis.
    Am J Gastroenterol. 2019 Jul 31. doi: 10.14309/ajg.0000000000000345.
    PubMed    


  173. ZHANG Y, Luo J, Wang C, Liu J, et al
    Long-Standing Unresolved Primary Biliary Cholangitis Leading to Systemic Amyloid A Amyloidosis With Predominant Liver Involvement: A Death Case.
    Am J Gastroenterol. 2019 Jul 31. doi: 10.14309/ajg.0000000000000338.
    PubMed    


  174. CIOCAN D, Voican CS, Barbu V, Corpechot C, et al
    Intrahepatic Cholestasis Owing to a Novel Heterozygous ABCG8 Mutation and SLC4A2 Polymorphism With Favorable Outcome Under Ursodeoxycholic Acid.
    Am J Gastroenterol. 2019 Jul 22. doi: 10.14309/ajg.0000000000000328.
    PubMed    


  175. KOWDLEY KV, Brown KE, Ahn J, Sundaram V, et al
    ACG Clinical Guideline: Hereditary Hemochromatosis.
    Am J Gastroenterol. 2019 Jul 22. doi: 10.14309/ajg.0000000000000315.
    PubMed     Abstract available


  176. RAMAI D, Ofosu A, Lai JK, Reddy M, et al
    Combined Hepatocellular Cholangiocarcinoma: A Population-Based Retrospective Study.
    Am J Gastroenterol. 2019 Jul 18. doi: 10.14309/ajg.0000000000000326.
    PubMed     Abstract available


  177. GONSALKORALA ES, Rahim MN, Heneghan MA
    Response to Mahla et al.
    Am J Gastroenterol. 2019;114:1179.
    PubMed    


  178. MAHLA RS
    Noninvasive Chronic Liver Disease Staging and Pregnancy Outcome Measures Are Not Limited to Albumin Bilirubin and Aspartate Aminotransferase to Platelet Ratio Index Scorings System.
    Am J Gastroenterol. 2019;114:1178.
    PubMed    


    June 2019
  179. EFE C, Tascilar K, Henriksson I, Lytvyak E, et al
    Validation of Risk Scoring Systems in Ursodeoxycholic Acid-Treated Patients With Primary Biliary Cholangitis.
    Am J Gastroenterol. 2019 Jun 19. doi: 10.14309/ajg.0000000000000290.
    PubMed     Abstract available


  180. ROSENBLATT R, Cohen-Mekelburg S, Shen N, Tafesh Z, et al
    Cirrhosis as a Comorbidity in Conditions Subject to the Hospital Readmissions Reduction Program.
    Am J Gastroenterol. 2019 Jun 10. doi: 10.14309/ajg.0000000000000257.
    PubMed     Abstract available


  181. BAJAJ JS, O'Leary JG, Tandon P, Wong F, et al
    Nosocomial Infections Are Frequent and Negatively Impact Outcomes in Hospitalized Patients With Cirrhosis.
    Am J Gastroenterol. 2019 Jun 6. doi: 10.14309/ajg.0000000000000280.
    PubMed     Abstract available


  182. YOKODA RT, Carey EJ
    Primary Biliary Cholangitis and Primary Sclerosing Cholangitis.
    Am J Gastroenterol. 2019 Jun 4. doi: 10.14309/ajg.0000000000000268.
    PubMed     Abstract available


  183. PETTA S, Wai-Sun Wong V, Bugianesi E, Fracanzani AL, et al
    Impact of Obesity and Alanine Aminotransferase Levels on the Diagnostic Accuracy for Advanced Liver Fibrosis of Noninvasive Tools in Patients With Nonalcoholic Fatty Liver Disease.
    Am J Gastroenterol. 2019;114:916-928.
    PubMed     Abstract available


  184. JUNG HS, Chang Y, Ryu S
    Response to Lai.
    Am J Gastroenterol. 2019;114:998-1000.
    PubMed    


  185. DEVARBHAVI H, Choudhury AK, Sharma MK, Maiwall R, et al
    Drug-Induced Acute-on-Chronic Liver Failure in Asian Patients.
    Am J Gastroenterol. 2019;114:929-937.
    PubMed     Abstract available


  186. LAI SW
    Smoking and Nonalcoholic Fatty Liver Disease.
    Am J Gastroenterol. 2019;114:998.
    PubMed    


  187. BYAMBASUKH O, Zelle D, Corpeleijn E
    Physical Activity, Fatty Liver, and Glucose Metabolism Over the Life Course: The Lifelines Cohort.
    Am J Gastroenterol. 2019;114:907-915.
    PubMed     Abstract available


  188. VUPPALANCHI R, Weber R, Russell S, Gawrieh S, et al
    Is Fasting Necessary for Individuals With Nonalcoholic Fatty Liver Disease to Undergo Vibration-Controlled Transient Elastography?
    Am J Gastroenterol. 2019;114:995-997.
    PubMed     Abstract available


    May 2019
  189. PISCAGLIA F, Sansone V
    Anticoagulation for Portal Vein Thrombosis in Cirrhosis.
    Am J Gastroenterol. 2019 May 20. doi: 10.14309/ajg.0000000000000274.
    PubMed    


  190. ROSENBLATT R, Cohen-Mekelburg S
    Fragmentation in Cirrhosis: The Excluded May Reveal the Full Story.
    Am J Gastroenterol. 2019 May 7. doi: 10.14309/ajg.0000000000000250.
    PubMed    


  191. SARKAR M, VanWagner LB, Terry JG, Carr JJ, et al
    Sex Hormone-Binding Globulin Levels in Young Men Are Associated With Nonalcoholic Fatty Liver Disease in Midlife.
    Am J Gastroenterol. 2019;114:758-763.
    PubMed     Abstract available


    April 2019
  192. ALUKAL JJ, Thuluvath PJ
    Gastrointestinal Failure in Critically Ill Patients With Cirrhosis.
    Am J Gastroenterol. 2019 Apr 5. doi: 10.14309/ajg.0000000000000226.
    PubMed     Abstract available


  193. DE GRACIA HAHN D, Duret A, Mann JP
    An AGTR1 Variant Worsens Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome.
    Am J Gastroenterol. 2019;114:556-559.
    PubMed     Abstract available


  194. GONZALEZ SA
    Antibiotic Prophylaxis for Spontaneous Bacterial Peritonitis: Benefit or Risk?
    Am J Gastroenterol. 2019;114:553-555.
    PubMed     Abstract available


  195. MUSSO G, Saba F, Cassader M, Paschetta E, et al
    Angiotensin II Type 1 Receptor rs5186 Gene Variant Predicts Incident NAFLD and Associated Hypertension: Role of Dietary Fat-Induced Pro-Inflammatory Cell Activation.
    Am J Gastroenterol. 2019;114:607-619.
    PubMed     Abstract available


  196. CHEUNG A, Figueredo C, Rinella ME
    Nonalcoholic Fatty Liver Disease: Identification and Management of High-Risk Patients.
    Am J Gastroenterol. 2019;114:579-590.
    PubMed     Abstract available


  197. CHANG Y, Cho YK, Cho J, Jung HS, et al
    Alcoholic and Nonalcoholic Fatty Liver Disease and Liver-Related Mortality: A Cohort Study.
    Am J Gastroenterol. 2019;114:620-629.
    PubMed     Abstract available


    March 2019
  198. KLOMPENHOUWER AJ, Alblas M, Vivica van Rosmalen B, Haring MPD, et al
    Development and Validation of a Model to Predict Regression of Large Size Hepatocellular Adenoma.
    Am J Gastroenterol. 2019 Mar 27. doi: 10.14309/ajg.0000000000000182.
    PubMed     Abstract available


  199. SANCHEZ-MONTES C, Aguilera V, Prieto M, Garcia-Campos M, et al
    Periesophageal Lymph Node Metastasis of Prostate Adenocarcinoma From Liver Transplant Donor.
    Am J Gastroenterol. 2019;114:378.
    PubMed    


  200. JUNG HS, Chang Y, Kwon MJ, Sung E, et al
    Smoking and the Risk of Non-Alcoholic Fatty Liver Disease: A Cohort Study.
    Am J Gastroenterol. 2019;114:453-463.
    PubMed     Abstract available


    February 2019
  201. OGIWARA S, Furihata M, Fukami K, Yamashita A, et al
    Hepatoid Adenocarcinoma With Enteroblastic Differentiation in the Sigmoid Colon: Lessons From a Rare Case.
    Am J Gastroenterol. 2019 Feb 26. doi: 10.14309/ajg.0000000000000176.
    PubMed    


  202. LABENZ C, Toenges G, Huber Y, Nagel M, et al
    Development and Validation of a Prognostic Score to Predict Covert Hepatic Encephalopathy in Patients With Cirrhosis.
    Am J Gastroenterol. 2019 Feb 18. doi: 10.14309/ajg.0000000000000121.
    PubMed     Abstract available


  203. MANCUSO A
    Anticoagulation for Portal Vein Thrombosis in Cirrhosis.
    Am J Gastroenterol. 2019 Feb 14. doi: 10.14309/ajg.0000000000000158.
    PubMed    


  204. FENG J, Qi X, Guo X, Qi X, et al
    Early-Stage Hepatocellular Carcinoma: Radiofrequency Ablation or Resection?
    Am J Gastroenterol. 2019;114:359.
    PubMed    


  205. KUSHNER T, Sarkar M, Tran T
    Noninvasive Tests for Prognosticating Outcomes in Patients With Chronic Liver Disease in Pregnancy: Ready for Prime Time?
    Am J Gastroenterol. 2019;114:209-211.
    PubMed     Abstract available


  206. GONSALKORALA ES, Cannon MD, Lim TY, Penna L, et al
    Non-Invasive Markers (ALBI and APRI) Predict Pregnancy Outcomes in Women With Chronic Liver Disease.
    Am J Gastroenterol. 2019;114:267-275.
    PubMed     Abstract available


    January 2019
  207. BAJAJ JS, Fagan A, White MB, Wade JB, et al
    Specific Gut and Salivary Microbiota Patterns Are Linked With Different Cognitive Testing Strategies in Minimal Hepatic Encephalopathy.
    Am J Gastroenterol. 2019 Jan 28. doi: 10.14309/ajg.0000000000000102.
    PubMed     Abstract available


  208. FENG Z, Marrero JA, Khaderi S, Singal AG, et al
    Design of the Texas Hepatocellular Carcinoma Consortium Cohort Study.
    Am J Gastroenterol. 2019 Jan 23. doi: 10.14309/ajg.0000000000000068.
    PubMed     Abstract available


  209. BAJAJ JS, Tandon P, O'Leary JG, Wong F, et al
    Outcomes in Patients With Cirrhosis on Primary Compared to Secondary Prophylaxis for Spontaneous Bacterial Peritonitis.
    Am J Gastroenterol. 2019 Jan 23. doi: 10.14309/ajg.0000000000000044.
    PubMed     Abstract available


  210. OKAFOR PN, Nnadi AK, Okoli O, Huang AE, et al
    Same- vs Different-Hospital Readmissions in Patients With Cirrhosis After Hospital Discharge.
    Am J Gastroenterol. 2019 Jan 18. doi: 10.14309/ajg.0000000000000050.
    PubMed     Abstract available


  211. PARIENTE A, Chazouilleres O, Causse X, Hanslik B, et al
    Baveno-VI-Guided Prediction of Esogastric Varices in Primary Biliary Cholangitis.
    Am J Gastroenterol. 2019 Jan 18. doi: 10.14309/ajg.0000000000000056.
    PubMed    


  212. SINGAL AK, Bataller R, Ahn J, Kamath PS, et al
    Response to Forrest et al.
    Am J Gastroenterol. 2019;114:176.
    PubMed    


  213. LOTLIKAR M, Pandey V, Chauhan S, Ingle M, et al
    Orbital Hematoma: A New Complication of Esophagogastroduodenoscopy.
    Am J Gastroenterol. 2019;114:181-182.
    PubMed    


  214. ASRANI SK, Hall L, Hagan M, Sharma S, et al
    Trends in Chronic Liver Disease-Related Hospitalizations: A Population-Based Study.
    Am J Gastroenterol. 2019;114:98-106.
    PubMed     Abstract available


    December 2018
  215. PETTINARI I, Vukotic R, Stefanescu H, Pecorelli A, et al
    Clinical Impact and Safety of Anticoagulants for Portal Vein Thrombosis in Cirrhosis.
    Am J Gastroenterol. 2018 Dec 11. pii: 10.1038/s41395-018-0421.
    PubMed     Abstract available


    November 2018
  216. YOUNOSSI ZM, Bernstein D, Shiffman ML, Kwo P, et al
    Diagnosis and Management of Primary Biliary Cholangitis.
    Am J Gastroenterol. 2018 Nov 14. pii: 10.1038/s41395-018-0390.
    PubMed     Abstract available


    October 2018
  217. WIELAND A, Kohli R
    Non-Alcoholic Steatohepatitis as a Growing Indication for Liver Transplantation: The Evolving Gender and Ethnic Trends.
    Am J Gastroenterol. 2018 Oct 23. pii: 10.1038/s41395-018-0373.
    PubMed     Abstract available


  218. ASKGAARD G, Kjaer MS, Tolstrup JS
    Opportunities to Prevent Alcoholic Liver Cirrhosis in High-risk Populations: A Systematic Review With Meta-analysis.
    Am J Gastroenterol. 2018 Oct 23. pii: 10.1038/s41395-018-0282.
    PubMed     Abstract available


  219. ESTEVEZ J, Yang JD, Leong J, Nguyen P, et al
    Clinical Features Associated with Survival Outcome in African-American Patients with Hepatocellular Carcinoma.
    Am J Gastroenterol. 2018 Oct 17. pii: 10.1038/s41395-018-0261.
    PubMed     Abstract available


  220. SHAH T, Tapper EB
    ERCP in Patients With Cirrhosis: "Risky Business" Or "Just Do It"?
    Am J Gastroenterol. 2018 Oct 12. pii: 10.1038/s41395-018-0271.
    PubMed     Abstract available


  221. YIP TC, Chan HL, Tse YK, Lam KL, et al
    On-Treatment Improvement of MELD Score Reduces Death and Hepatic Events in Patients With Hepatitis B-Related Cirrhosis.
    Am J Gastroenterol. 2018 Oct 12. pii: 10.1038/s41395-018-0247.
    PubMed     Abstract available


  222. MOCTEZUMA-VELAZQUEZ C, Saffioti F, Tasayco-Huaman S, Casu S, et al
    Non-invasive Prediction of High-risk Varices in Patients with Primary Biliary Cholangitis and Primary Sclerosing Cholangitis.
    Am J Gastroenterol. 2018 Oct 12. pii: 10.1038/s41395-018-0265.
    PubMed     Abstract available


  223. AGARWAL PD, Lucey MR
    Genetic Variations Linked to Hepatocellular Carcinoma: Personalized Medicine Takes a Step Forward.
    Am J Gastroenterol. 2018 Oct 5. pii: 10.1038/s41395-018-0260.
    PubMed     Abstract available


    September 2018
  224. NEY M, Tangri N, Dobbs B, Bajaj J, et al
    Predicting Hepatic Encephalopathy-Related Hospitalizations Using a Composite Assessment of Cognitive Impairment and Frailty in 355 Patients With Cirrhosis.
    Am J Gastroenterol. 2018 Sep 28. pii: 10.1038/s41395-018-0243.
    PubMed     Abstract available


  225. LEAL C, Prado V, Colan J, Chavez-Rivera K, et al
    Adverse Events and Acute Chronic Liver Failure in Patients With Cirrhosis Undergoing Endoscopic Retrograde Cholangiopancreatography: A Multicenter Matched-Cohort Study.
    Am J Gastroenterol. 2018 Sep 3. pii: 10.1038/s41395-018-0218.
    PubMed     Abstract available


  226. PETRICK JL, Thistle JE, Zeleniuch-Jacquotte A, Zhang X, et al
    Body Mass Index, Diabetes and Intrahepatic Cholangiocarcinoma Risk: The Liver Cancer Pooling Project and Meta-analysis.
    Am J Gastroenterol. 2018 Sep 3. pii: 10.1038/s41395-018-0207.
    PubMed     Abstract available


    August 2018
  227. CARRION AF, Martin P
    When to Refer for Liver Transplantation.
    Am J Gastroenterol. 2018 Aug 31. pii: 10.1038/s41395-018-0242.
    PubMed    


    July 2018
  228. ACHARYA C, Bajaj JS
    Current Management of Hepatic Encephalopathy.
    Am J Gastroenterol. 2018 Jul 13. pii: 10.1038/s41395-018-0179.
    PubMed     Abstract available


  229. ADEBAYO D, Neong SF, Wong F
    Refractory Ascites in Liver Cirrhosis.
    Am J Gastroenterol. 2018 Jul 5. pii: 10.1038/s41395-018-0185.
    PubMed     Abstract available


    June 2018
  230. VIOLI F, Talerico G, Basili S
    A Closer Look at Platelet Count and Prediction of Bleeding in Cirrhotic Patients.
    Am J Gastroenterol. 2018 Jun 29. pii: 10.1038/s41395-018-0191.
    PubMed    


  231. HUSSEN N, Zhu L, Tetangco E, Ellison S, et al
    Hepatoptosis in a Patient with Alcoholic Hepatitis.
    Am J Gastroenterol. 2018 Jun 29. pii: 10.1038/s41395-018-0182.
    PubMed    


  232. GIANNINI EG, Bodini G, Furnari M, Marabotto E, et al
    A Closer Look at Factors Associated With Bleeding in Cirrhotic Patients.
    Am J Gastroenterol. 2018 Jun 18. pii: 10.1038/s41395-018-0128.
    PubMed    


  233. GIANNINI EG, Moscatelli A, Pellegatta G, Vitale A, et al
    Correction: Application of the Intermediate-Stage Subclassification to Patients With Untreated Hepatocellular Carcinoma.
    Am J Gastroenterol. 2018 Jun 18. pii: 10.1038/s41395-018-0131.
    PubMed     Abstract available


  234. LEE EW, Saab S, Kaldas F, Fletcher S, et al
    Coil-Assisted Retrograde Transvenous Obliteration (CARTO): An Alternative Treatment Option for Refractory Hepatic Encephalopathy.
    Am J Gastroenterol. 2018 Jun 14. pii: 10.1038/s41395-018-0109.
    PubMed     Abstract available


  235. HUANG R, Wang J, Xia J, Zhang Z, et al
    Platelet Count and Prediction of Bleeding in Patients With Liver Cirrhosis.
    Am J Gastroenterol. 2018 Jun 12. pii: 10.1038/s41395-018-0152.
    PubMed    


  236. STICKEL F, Buch S, Nischalke HD, Weiss KH, et al
    Correction: Genetic Variants in PNPLA3 and TM6SF2 Predispose to the Development of Hepatocellular Carcinoma in Individuals With Alcohol-Related Cirrhosis.
    Am J Gastroenterol. 2018 Jun 11. pii: 10.1038/s41395-018-0118.
    PubMed     Abstract available


  237. BAJAJ JS, Tandon P, O'Leary JG, Biggins SW, et al
    The Impact of Albumin Use on Resolution of Hyponatremia in Hospitalized Patients With Cirrhosis.
    Am J Gastroenterol. 2018 Jun 8. pii: 10.1038/s41395-018-0119.
    PubMed     Abstract available


  238. SHIN JW, Jung SW, Lee SB, Lee BU, et al
    Medication Nonadherence Increases Hepatocellular Carcinoma, Cirrhotic Complications, and Mortality in Chronic Hepatitis B Patients Treated With Entecavir.
    Am J Gastroenterol. 2018 Jun 8. pii: 10.1038/s41395-018-0093.
    PubMed     Abstract available


  239. MOURAD FH, Leong RW
    Gas In The Hepatic Portal Venous System Associated With Ischemic Colitis.
    Am J Gastroenterol. 2018 Jun 8. pii: 10.1038/s41395-018-0110.
    PubMed    


  240. MITSIALIS V, Lee LS
    Metastasis of Hepatocellular Carcinoma to Distal Colon Associated With Inferior Mesenteric Arteriovenous Fistula and Tumor Thrombus: a Case Report.
    Am J Gastroenterol. 2018 Jun 8. pii: 10.1038/s41395-018-0101.
    PubMed    


  241. BAJAJ JS, Acharya C, Fagan A, White MB, et al
    Proton Pump Inhibitor Initiation and Withdrawal affects Gut Microbiota and Readmission Risk in Cirrhosis.
    Am J Gastroenterol. 2018 Jun 6. pii: 10.1038/s41395-018-0085.
    PubMed     Abstract available


  242. LAI JC, Tandon P
    How I Approach It: Improving Nutritional Status in Patients With Cirrhosis.
    Am J Gastroenterol. 2018 Jun 5. pii: 10.1038/s41395-018-0080.
    PubMed    


    May 2018
  243. CHASCSA DM, Vargas HE
    The gastroenterologist's guide to management of the post-liver transplant patient.
    Am J Gastroenterol. 2018 May 11. pii: 10.1038/s41395-018-0049.
    PubMed     Abstract available


  244. HERNAEZ R, El-Serag HB
    How we approach it: treatment options for hepatocellular carcinoma.
    Am J Gastroenterol. 2018 May 1. pii: 10.1038/s41395-018-0008.
    PubMed    


    April 2018
  245. LENCI I, Milana M, Toti L, Palmieri G, et al
    An unusual duodenal polyp causing anemia in a liver-transplanted patient.
    Am J Gastroenterol. 2018 Apr 24. pii: 10.1038/s41395-018-0046.
    PubMed    


  246. GINER R
    Spanish Women Hepatologists: Breaking The Glass Ceiling?
    Am J Gastroenterol. 2018;113:622-623.
    PubMed    


  247. BRUMBLE L, Keaveny AP
    Editorial: The Risky Business of Fungal Infections in Patients with Cirrhosis.
    Am J Gastroenterol. 2018;113:564-566.
    PubMed     Abstract available


    March 2018
  248. NEIJENHUIS M, Gevers TJG, Atwell TD, Gunneson TJ, et al
    Development and Validation of a Patient-Reported Outcome Measurement for Symptom Assessment in Cirrhotic Ascites.
    Am J Gastroenterol. 2018 Mar 20. pii: ajg201818. doi: 10.1038/ajg.2018.
    PubMed     Abstract available


  249. MENDEZ-SANCHEZ N, Chavez-Tapia NC, Almeda-Valdes P, Uribe M, et al
    The management of incidental fatty liver found on imaging. What do we need to do?
    Am J Gastroenterol. 2018 Mar 16. pii: 10.1038/s41395-018-0047.
    PubMed    


  250. STICKEL F, Buch S, Nischalke HD, Weiss KH, et al
    Genetic variants in PNPLA3 and TM6SF2 predispose to the development of hepatocellular carcinoma in individuals with alcohol-related cirrhosis.
    Am J Gastroenterol. 2018 Mar 13. pii: 10.1038/s41395-018-0041.
    PubMed     Abstract available


  251. TAPPER EB, Parikh ND, Waljee AK, Volk M, et al
    Diagnosis of Minimal Hepatic Encephalopathy: A Systematic Review of Point-of-Care Diagnostic Tests.
    Am J Gastroenterol. 2018 Mar 13. pii: ajg20186. doi: 10.1038/ajg.2018.
    PubMed     Abstract available


  252. THOMSON MJ, Tapper EB, Lok ASF
    Dos and Don'ts in the Management of Cirrhosis: A View from the 21st Century.
    Am J Gastroenterol. 2018 Mar 9. pii: 10.1038/s41395-018-0028.
    PubMed    


    February 2018
  253. VENKATESH SK, Talwalkar JA
    When and how to use magnetic resonance elastography for patients with liver disease in clinical practice.
    Am J Gastroenterol. 2018 Feb 27. pii: 10.1038/s41395-018-0012.
    PubMed    


    January 2018
  254. LAINE L, Laursen SB, Zakko L, Dalton HR, et al
    Severity and Outcomes of Upper Gastrointestinal Bleeding With Bloody Vs. Coffee-Grounds Hematemesis.
    Am J Gastroenterol. 2018 Jan 30. pii: ajg20185. doi: 10.1038/ajg.2018.
    PubMed     Abstract available


    December 2017
  255. HUANG YW, Lee CL, Yang SS, Fu SC, et al
    Corrigendum: Statins Reduce the Risk of Cirrhosis and Its Decompensation in Chronic Hepatitis B Patients: A Nationwide Cohort Study.
    Am J Gastroenterol. 2017 Dec 26. pii: ajg2017494. doi: 10.1038/ajg.2017.
    PubMed     Abstract available


  256. BASILI S, Raparelli V, Napoleone L, Talerico G, et al
    Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study.
    Am J Gastroenterol. 2017 Dec 19. pii: ajg2017457. doi: 10.1038/ajg.2017.
    PubMed     Abstract available


  257. LAI JC, Covinsky KE, McCulloch CE, Feng S, et al
    The Liver Frailty Index Improves Mortality Prediction of the Subjective Clinician Assessment in Patients With Cirrhosis.
    Am J Gastroenterol. 2017 Dec 12. pii: ajg2017443. doi: 10.1038/ajg.2017.
    PubMed     Abstract available


  258. HARMS MH, Lammers WJ, Thorburn D, Corpechot C, et al
    Major Hepatic Complications in Ursodeoxycholic Acid-Treated Patients With Primary Biliary Cholangitis: Risk Factors and Time Trends in Incidence and Outcome.
    Am J Gastroenterol. 2017 Dec 12. pii: ajg2017440. doi: 10.1038/ajg.2017.
    PubMed     Abstract available


  259. BUNCHORNTAVAKUL C, Reddy KR
    HCV Therapy in Decompensated Cirrhosis before or after Liver Transplantation: A Paradoxical Quandary.
    Am J Gastroenterol. 2017 Dec 5. pii: ajg2017435. doi: 10.1038/ajg.2017.
    PubMed    


  260. VARKARIS A, Lewis DW, Nugent FW
    Preserved Liver Transplant After PD-1 Pathway Inhibitor for Hepatocellular Carcinoma.
    Am J Gastroenterol. 2017;112:1895-1896.
    PubMed    


  261. LIU K, Wong VW, Lau K, Liu SD, et al
    Prognostic Value of Controlled Attenuation Parameter by Transient Elastography.
    Am J Gastroenterol. 2017;112:1812-1823.
    PubMed     Abstract available


  262. BARATTA F, Pastori D, Polimeni L, Bucci T, et al
    Adherence to Mediterranean Diet and Non-Alcoholic Fatty Liver Disease: Effect on Insulin Resistance.
    Am J Gastroenterol. 2017;112:1832-1839.
    PubMed     Abstract available


    October 2017
  263. SINGAL AG
    CON: Hepatocellular Carcinoma Surveillance: In Need of Higher-Quality Data.
    Am J Gastroenterol. 2017 Oct 10. doi: 10.1038/ajg.2017.
    PubMed    


  264. REIG A, Sese P, Pares A
    Effects of Bezafibrate on Outcome and Pruritus in Primary Biliary Cholangitis With Suboptimal Ursodeoxycholic Acid Response.
    Am J Gastroenterol. 2017 Oct 10. doi: 10.1038/ajg.2017.
    PubMed     Abstract available


  265. PARIKH ND
    PRO: Hepatocellular Carcinoma Surveillance: A Useful Tool Against the Rising Tide of HCC.
    Am J Gastroenterol. 2017 Oct 3. doi: 10.1038/ajg.2017.
    PubMed    


  266. KECK C, Shetty A, Mischen B, Willner I, et al
    Hepatic Splenosis Masquerading as Hepatocellular Carcinoma in a Chronic Hepatitis C Patient.
    Am J Gastroenterol. 2017;112:1493.
    PubMed    


  267. PRICE JC, Tien PC
    Editorial: Statins and Liver Disease: Is it Time to Recommend Statins to Prevent Liver Disease Progression?
    Am J Gastroenterol. 2017;112:1506-1507.
    PubMed     Abstract available


    September 2017
  268. UNGPRASERT P, Crowson CS, Simonetto DA, Matteson EL, et al
    Clinical Characteristics and Outcome of Hepatic Sarcoidosis: A Population-Based Study 1976-2013.
    Am J Gastroenterol. 2017 Sep 5. doi: 10.1038/ajg.2017.
    PubMed     Abstract available


  269. ARGO CK, Caldwell SH
    Editorial: Severe Acute Liver Injury: Cause Connects to Outcome.
    Am J Gastroenterol. 2017;112:1397-1399.
    PubMed     Abstract available


  270. CHALASANI N, Reddy KRK, Fontana RJ, Barnhart H, et al
    Idiosyncratic Drug Induced Liver Injury in African-Americans Is Associated With Greater Morbidity and Mortality Compared to Caucasians.
    Am J Gastroenterol. 2017;112:1382-1388.
    PubMed     Abstract available


  271. KOCH DG, Speiser JL, Durkalski V, Fontana RJ, et al
    The Natural History of Severe Acute Liver Injury.
    Am J Gastroenterol. 2017;112:1389-1396.
    PubMed     Abstract available


    August 2017
  272. PIANO S, Morando F, Carretta G, Tonon M, et al
    Predictors of Early Readmission in Patients With Cirrhosis After the Resolution of Bacterial Infections.
    Am J Gastroenterol. 2017 Aug 29. doi: 10.1038/ajg.2017.
    PubMed     Abstract available


  273. TSENG TC, Liu CJ, Su TH, Yang WT, et al
    Fibrosis-4 Index Helps Identify HBV Carriers With the Lowest Risk of Hepatocellular Carcinoma.
    Am J Gastroenterol. 2017 Aug 29. doi: 10.1038/ajg.2017.
    PubMed     Abstract available


  274. SCHAFFELLNER S, Stadlbauer V, Sereinigg M, Miller H, et al
    Niacin-Associated Acute Hepatotoxicity Leading to Emergency Liver Transplantation.
    Am J Gastroenterol. 2017;112:1345-1346.
    PubMed    


  275. LUEDKE C, Ravindra K, Hertzberg B, Berg C, et al
    A Rapidly Enlarging Mullerian-Derived Hepatic Adenomyoma Clinically Mimicking Hepatic Adenoma in a Pregnant Woman.
    Am J Gastroenterol. 2017;112:1217.
    PubMed    


  276. GEORGE NE, Raghavapuram S, Banerjee D, Al-Shoha M, et al
    Ectopic Hepatocellular Carcinoma within a Choledochal Cyst Diagnosed Using Single-Operator Digital Cholangioscopy.
    Am J Gastroenterol. 2017;112:1347-1348.
    PubMed    


  277. BUGIANESI E, Bizzarri C, Rosso C, Mosca A, et al
    Low Birthweight Increases the Likelihood of Severe Steatosis in Pediatric Non-Alcoholic Fatty Liver Disease.
    Am J Gastroenterol. 2017;112:1277-1286.
    PubMed     Abstract available


    June 2017
  278. KANWAL F, Tansel A, Kramer JR, Feng H, et al
    Trends in 30-Day and 1-Year Mortality Among Patients Hospitalized With Cirrhosis From 2004 to 2013.
    Am J Gastroenterol. 2017 Jun 13. doi: 10.1038/ajg.2017.
    PubMed     Abstract available


  279. KAMAL S, Khan MA, Seth A, Cholankeril G, et al
    Beneficial Effects of Statins on the Rates of Hepatic Fibrosis, Hepatic Decompensation, and Mortality in Chronic Liver Disease: A Systematic Review and Meta-Analysis.
    Am J Gastroenterol. 2017 Jun 6. doi: 10.1038/ajg.2017.
    PubMed     Abstract available


  280. LIU J, Ghaziani TT, Wolf JL
    Acute Fatty Liver Disease of Pregnancy: Updates in Pathogenesis, Diagnosis, and Management.
    Am J Gastroenterol. 2017;112:838-846.
    PubMed     Abstract available


  281. PHAN F, Rowe K, Salyers WJ
    A Risky Relationship: The Splenic Artery and Walled-Off Pancreatic Necrosis.
    Am J Gastroenterol. 2017;112:834.
    PubMed    


    May 2017
  282. KHAN SA, Pham C, Seah D, Ranatunga D, et al
    Acute Life-Threatening Portal Hypertension After Portosystemic Shunt Embolization.
    Am J Gastroenterol. 2017;112:816-818.
    PubMed    


  283. LO GH
    Did Carvedilol Really Have More Severe Adverse Events than Propranolol in Cirrhotic Patients?
    Am J Gastroenterol. 2017;112:808.
    PubMed    


  284. SARKAR M, Wellons M, Cedars MI, VanWagner L, et al
    Testosterone Levels in Pre-Menopausal Women are Associated With Nonalcoholic Fatty Liver Disease in Midlife.
    Am J Gastroenterol. 2017;112:755-762.
    PubMed     Abstract available


  285. MCPHERSON S, Hardy T, Dufour JF, Petta S, et al
    Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis.
    Am J Gastroenterol. 2017;112:740-751.
    PubMed     Abstract available


  286. STINE JG, Rinella ME
    Editorial: Age and Non-Invasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease: Time to Adjust the Clock?
    Am J Gastroenterol. 2017;112:752-754.
    PubMed     Abstract available


    April 2017
  287. WONG F, O'Leary JG, Reddy KR, Garcia-Tsao G, et al
    Acute Kidney Injury in Cirrhosis: Baseline Serum Creatinine Predicts Patient Outcomes.
    Am J Gastroenterol. 2017 Apr 25. doi: 10.1038/ajg.2017.
    PubMed     Abstract available


  288. LEE MH, Hsiao TI, Subramaniam SR, Le AK, et al
    HCV Genotype 6 Increased the Risk for Hepatocellular Carcinoma Among Asian Patients With Liver Cirrhosis.
    Am J Gastroenterol. 2017 Apr 25. doi: 10.1038/ajg.2017.
    PubMed     Abstract available


  289. CHEN SC, Chao Y, Yang MH
    Complete Response to the Combination of Pembrolizumab and Sorafenib for Metastatic Hepatocellular Carcinoma: A Case Report.
    Am J Gastroenterol. 2017;112:659-660.
    PubMed    


    March 2017
  290. JOHN BV, Khalili K
    Editorial: Not All Nodules Are Created Equal: A Personalized Approach to Indeterminate (<2 cm) Nodules Identified on HCC Surveillance.
    Am J Gastroenterol. 2017;112:471-472.
    PubMed     Abstract available


    January 2017
  291. FELDMAN A, Eder SK, Felder TK, Kedenko L, et al
    Clinical and Metabolic Characterization of Lean Caucasian Subjects With Non-alcoholic Fatty Liver.
    Am J Gastroenterol. 2017;112:102-110.
    PubMed     Abstract available


  292. ARGO CK, Henry ZH
    Editorial: "Lean" NAFLD: Metabolic Obesity with Normal BMI... Is It in the Genes?
    Am J Gastroenterol. 2017;112:111-113.
    PubMed     Abstract available


    October 2016
  293. FLOREANI A, Mangini C, Reig A, Franceschet I, et al
    Thyroid Dysfunction in Primary Biliary Cholangitis: A Comparative Study at Two European Centers.
    Am J Gastroenterol. 2016 Oct 25. doi: 10.1038/ajg.2016.
    PubMed     Abstract available


    July 2016
  294. FLORES A, Asrani SK
    Editorial: Magnetic Resonance Elastography and Non-Alcoholic Fatty Liver Disease: Time for an Upgrade?
    Am J Gastroenterol. 2016;111:995-6.
    PubMed     Abstract available


    June 2016
  295. KISHORE R, Loomba R, Sterling RK
    Editorial: A New Spin on Magnetic Resonance Elastography.
    Am J Gastroenterol. 2016;111:834-7.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: